Page last updated: 2024-11-12

bacitracin methylenedisalicylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bacitracin methylenedisalicylic acid: RN given refers to Bacitracin, methylenebis(2-hydroxybenzoate) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11980094
MeSH IDM0080627

Synonyms (14)

Synonym
55852-84-1
kemitracin 10
bacitracin methylenedisalicylic acid
md bacitracin
fortracin (bacitracin-md)
caswell no. 066d
methylenebis(2-hydroxybenzoate)bacitracin
bacitracin, methylenebis(2-hydroxybenzoate) (salt)
bacitracin methylene disalicylate
bacitracin methylenedisalicylate
einecs 259-862-3
bacitracin, methylenebis(2-hydroxybenzoate)
unii-jgv6oj52ft
jgv6oj52ft ,

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"The efficacy of bacitracin methylene disalicylate (BMD) in the management of necrotic enteritis (NE) when fed in combination with narasin was investigated in a floor-pen study of 2,000 broiler chickens using a Clostridium perfringens inoculum challenge model."( The efficacy of bacitracin methylene disalicylate when fed in combination with narasin in the management of necrotic enteritis in broiler chickens.
Barnum, DA; Brennan, J; Skinner, J; Wilson, J, 2003
)
0.32

Dosage Studied

ExcerptRelevanceReference
" One-day-old turkeys were dosed per os with tryptose phosphate broth or a supernatant derived from gastrointestinal tracts of poults with SS."( Effect of bacitracin methylene disalicylate on turkey poult performance in the presence and absence of stunting syndrome.
Sell, JL; Trampel, DW,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (21.62)18.7374
1990's3 (8.11)18.2507
2000's6 (16.22)29.6817
2010's18 (48.65)24.3611
2020's2 (5.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.14 (24.57)
Research Supply Index3.87 (2.92)
Research Growth Index5.01 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials7 (17.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (82.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]